Novo­cure bags mesothe­lioma nod for elec­tric fields can­cer ther­a­py with some lim­i­ta­tions

Novo­cure has se­cured the FDA’s bless­ing for an­oth­er use of its tu­mor treat­ing fields: ma­lig­nant pleur­al mesothe­lioma, a rare can­cer that de­vel­ops in the lin­ings …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER